Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Axitinib
Related studies linked through entity extraction aliases.
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
- Status
- SUSPENDED
- Phase
- PHASE2
Combination of Toripalimab and JS004 Therapy for ccRCC
- Status
- RECRUITING
- Phase
- PHASE2
CARE1 Pragmatic Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE3
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
- Status
- RECRUITING
- Phase
- PHASE2
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
- Status
- RECRUITING
- Phase
- PHASE2
Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)
- Status
- COMPLETED
- Phase
- N/A